Goldman Sachs’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
AC
VCM
DCM
Goldman Sachs's INGN Position: Q1 2026 in Review
Goldman Sachs reduced its Inogen (INGN) stake by 1.6% in Q1 2026, selling an estimated $56.6K and leaving 580,100 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4013.
Goldman Sachs first reported a position in INGN in Q2 2014 and has held it in 44 quarters since. The position peaked at $50.9M in Q3 2018. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.
- Goldman Sachs held 580,100 shares of Inogen worth $3.59M as of Q1 2026.
- Goldman Sachs sold 9,173 Inogen shares in Q1 2026, an estimated $56.6K.
- Inogen made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4013 holding.
- Goldman Sachs first reported a position in Inogen in Q2 2014 and has held it in 44 quarters since.
- Goldman Sachs's Inogen position peaked at $50.9M in Q3 2018.
- 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.